Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Importance of Positive Expiratory Pressure Associated With the In-exsufflator in Patients With Amyotrophic Lateral Sclerosis on the Effectiveness of Therapy

NCT06249412 is registered in ClinicalTrials.gov with Groupe Hospitalier du Havre as lead sponsor.

NCT NCT06249412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06249412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Importance of Positive Expiratory Pressure Associated With the In-exsufflator in Patients With Amyotrophic Lateral Sclerosis on the Effectiveness of Therapy
Lead sponsor
Groupe Hospitalier du Havre
Phase
Not applicable
Overall status
Recruiting
Start date
December 19, 2024
Completion date
March 1, 2027
Enrollment
11 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis als7